deltatrials
Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT04400019

Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM) (PREVICHARM)

Prevention of COVID19 Infection by the Administration of Hydroxychloroquine to Institutionalized Older People and Nursing Home Staff. Controlled Clinical Trial, Randomized Triple Blind by Clusters (PREVICHARM Study)

Sponsor: Carlos III Health Institute

Updated 6 times since 2020 Last updated: Sep 26, 2020 Started: Sep 30, 2020 Primary completion: Dec 15, 2020 Completion: Apr 1, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Coronavirus Infection and Hydroxychloroquine and is currently ongoing. Carlos III Health Institute leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jun 2020 – ~Oct 2020 · 4 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotNot Yet Recruiting~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2/PHASE3

    Status: Unknown StatusUnknown · Phase: PHASE2_PHASE3PHASE2/PHASE3

  3. Nov 2022 — Jul 2024 [monthly]

    Unknown Status PHASE2_PHASE3

    Status: Not Yet RecruitingUnknown Status

  4. Jan 2021 — Nov 2022 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

  5. Oct 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

Show 1 earlier version
  1. Jun 2020 — Oct 2020 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Carlos III Health Institute
  • Instituto de Investigacion Biomedica de Malaga
  • University of Malaga
Data source: University of Malaga

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.